Featured at ACR Convergence 2022
Below, Walter P. Maksymowych, MB ChB, FACP, FRCP(C), offers his picks for the top research in psoriatic arthritis presented at ACR Convergence 2022. We report on a session in which Joseph Merola, MD, MMSc, discussed treatment strategies for patients with difficult-to-treat psoriatic arthritis. And a patient presents her story of how improved communication with her rheumatologist improved her disease control. See these stories below.
Visit Our Resource Center
The axial phenotype of psoriatic arthritis (axPsA) is an excellent example of a major controversy in rheumatology that has become the focus of attention because of the emergence of new therapies with different mechanisms of action for alleviating joint inflammation. In an article earlier this year, Dr. Maksymowych discussed what is currently known about the imaging of axPsA, how imaging may complement clinical assessment, the pitfalls of imaging assessments used in routine evaluation of axPsA and how imaging can be used to help define patients with axPsA. To read this article, and for more information on psoriatic arthritis, visit our Psoriatic Arthritis Resource Center.
